Summary
The product Turinabol, manufactured by Helion Labs, underwent independent testing to verify its authenticity and potency. The sample, identified as Turinabol, was submitted by Helion Labs and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis confirmed the presence of Turinabol with measured concentrations of 22.27 mg and 22.88 mg.
The testing process began on 3 June 2024, with the sample received on 4 July 2024, and the analysis completed on 10 July 2024. While the results confirm the product’s composition, scrutiny of manufacturer-submitted samples remains essential to ensure reliability. Independent third-party testing remains critical to validate these findings comprehensively. This report serves as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Helion Labs
- Product Name: Turinabol
- Active Ingredient: Turinabol
- Batch Number: Unknown
- Expiration Date: Not provided
- Delivery Method: Oral
Sample Acquisition and Testing
- Task Number: #44943
- Testing Ordered: 3 June 2024
- Sample Received: 4 July 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Helion Labs (Manufacturer)
- Analysis Paid For By: Helion Labs (Manufacturer)
Testing Results
- Specification: 10 mg
- Measured Concentration: 22.27 mg; 22.88 mg
- Accuracy: Not available (No reference dosage stated)
Verification Details
- Verification URL: https://janoshik.com/tests/44943_U61FK3GM5ULX
Evaluation of Manufacturer-Submitted Testing
This analysis confirms the presence of Turinabol in the tested product but highlights the need for careful evaluation due to manufacturer-submitted samples. Since Helion Labs both submitted and funded the test, further independent verification is recommended to assess batch-to-batch consistency. While Janoshik Analytical is known for its transparency and rigorous testing protocols, these findings would benefit from additional third-party testing across multiple samples.
Conclusion
The analysis verifies that the product contains Turinabol with measured concentrations of 22.27 mg and 22.88 mg. While this confirms the expected composition, independent testing remains necessary to ensure consistency across batches. This report is provided to support educational and harm reduction efforts, helping consumers make informed choices regarding pharmaceutical products.
Disclaimer
This report is published for educational and harm reduction purposes. Manufacturer-submitted testing may involve inherent biases; however, it can still provide useful data when critically assessed alongside third-party or independent results. Readers are encouraged to use this information responsibly.
